R are genetic diseases are challenging for patients and their families—made all the more overwhelming because symptoms tend ...

CRISPR Therapeutics could stage a comeback thanks to clinical and commercial progress. There are many promising corporations ...

PROTEUS, a system designed to harness “directed evolution,” can speed the process up by years, or even decades.

The gene-editing platform known as Crispr is widely used by researchers in scientific laboratories in their search for new ...

UConn Health and Connecticut Children's have made history by dosing the first patient in a clinical trial using gene editing to treat glycogen storage ...

Fourteen million people worldwide suffer from enlarged hearts, or hypertrophic cardiomyopathy (HCM), a genetic disease that ...

CRISPR Therapeutics CRSP and Intellia Therapeutics NTLA are leading developers of therapies that utilize the Nobel Prize-winning CRISPR/Cas9 gene editing technology. While CRSP is the first and only ...

The PROTEUS system uses biological artificial intelligence to evolve molecules within mammalian cells, enhancing gene ...

When the COVID-19 pandemic swept across the world in 2020, the mRNA vaccines came to the rescue of many people—but in the ...

Abu Dhabi (DoH), the regulator of the healthcare sector in Abu Dhabi, has announced a landmark partnership with the University of California, San Francisco (UCSF) and the Innovative Genomics Institute ...